Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Sony Group Corp — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B), while Sony Group Corp trades at $24.12 (market cap $136.87B). The key difference: Sony Group Corp is far larger — about 22.7× Iovance Biotherapeutics Inc. Common Stock's market cap, and Sony Group Corp pays a 0.66% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Sony Group Corp for 96 Days on average.
| IOVA | SONY | |
|---|---|---|
Market Cap | $6.04B | $136.87B |
Volume | 14,805,993 | 5,364,503 |
Sector | Health | Technology |
52-Week High | $14.82 | $30.26 |
52-Week Low | $1.81 | $19.32 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $5.97B | $134.77B |
Dividend Yield | — | 0.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sony trades at $24.12, up 2.55% today, with a bullish technical outlook supported by moving averages. The company reported mixed quarterly results with two beats and one miss, while full-year 2025 showed strong revenue of $12.96T and net income of $1.14T. Analyst sentiment remains positive with 11 buy ratings and no sell recommendations, though 2026 projections indicate potential profitability challenges with negative net income margins.
Sony presents a compelling value opportunity with reasonable valuation metrics (P/E 20.34, P/S 1.79) and strong cash flow generation, but faces headwinds from projected 2026 profitability decline. The entertainment and technology conglomerate benefits from diverse revenue streams and intellectual property strength, though investors should monitor execution risks amid competitive pressures and macroeconomic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
